Evidence map›Paper›PMID 33405021›Full record

ReviewInflammation2021

The Role of α7nAChR-Mediated Cholinergic Anti-inflammatory Pathway in Immune Cells.

Yi-Jin Wu, Li Wang, Chao-Fan Ji, Shao-Fei Gu, Qin Yin, Jian Zuo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Inflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Vagus nerve stimulation and pulmonary outcomes: a scoping review of preclinical and clinical evidence.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. [Research progress on vagus nerve stimulation in the treatment of chronic pain].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yi-Jin WuThe Second Affiliated Hospital of Wannan Medical College, Wuhu, 241000, China.
Li WangDepartment of Pharmacy, Wuhu Medicine and Health School, Wuhu, 241000, China.
Chao-Fan JiDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Wuhu, 241000, China.
Shao-Fei GuDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Wuhu, 241000, China.
Qin YinThe Second Affiliated Hospital of Wannan Medical College, Wuhu, 241000, China. yq0553@163.com.
Jian ZuoDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Wuhu, 241000, China. zuojian8178@163.com.ORCID http://orcid.org/0000-0003-4940-9408
Wannan Medical College · CNFirst Affiliated Hospital of Wannan Medical College · CNWuhu Institute of Technology · CN

Funding

Key Project of Natural Science Foundation of Anhui Province for College Scholar KJ2018A0249National Natural Science Foundation of China 81973828Talent Cultivation and International Academic Visiting Project for College Scholar of Anhui Province gxfxZD2016163
6 · The paper itself

Abstract

Alpha 7 nicotinic acetylcholine receptor (α7nAChR) is widely distributed in the nervous and non-cholinergic immune systems. It is necessary for the cholinergic transmitter to participate in the regulation of inflammatory response and is the key element of cholinergic anti-inflammatory pathway (CAP). Because of the profound impact of CAP on the immune system, α7nAChR is considered as a potential therapeutic target for the treatment of inflammatory diseases. Available evidences confirmed that manipulation of CAP by activating α7nAChR with either endogenous acetylcholine (ACh) or cholinergic agonists can substantially alleviate inflammatory responses both in vivo and in vitro. However, the mechanism through which CAP curbs the excessive pro-inflammatory responses and maintains immune homeostasis is not fully understood. Obtained clues suggest that the crosstalk between CAP and classical inflammatory pathways is the key to elucidate the anti-inflammatory mechanism, and the impacts of CAP activation in α7nAChR-expressing immune cells are the foundation of the immunoregulatory property. In this article, we review and update the knowledge concerning the progresses of α7nAChR-based CAP, including α7nAChR properties, signal transductions, interactions with classic immune pathways, and immunoregulatory functions in different immune cells. Certain critical issues to be addressed are also highlighted. By providing a panoramic view of α7nAChR, the summarized evidences will pave the way for the development of novel anti-inflammatory reagents and strategy and inspire further researches.

Indexed as

Signal TransductionAcetylcholinealpha7 Nicotinic Acetylcholine ReceptorAnimalsAnti-Inflammatory AgentsCholinergic AgonistsHumansImmune SystemInflammationInflammation MediatorsAcetylcholinealpha7 Nicotinic Acetylcholine ReceptorAnti-Inflammatory AgentsCholinergic AgonistsChrna7 protein, humanInflammation Mediatorsimmune cellsinflammationNF-κBT cellsα7nAChR

Identifiers

PMID33405021
OpenAlexW3119611628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.